FDA Inspection 988583 — Octapharma Plasma, Inc.
The FDA completed an inspection of Octapharma Plasma, Inc. on August 31, 2016 in Las Vegas, NV. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 31, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Las Vegas, NV (United States)